CHRU de Lille- Hôpital Roger Salengro

Lille, Cedex 59037

0 studies enrolling now · 3 studies all time

What they study most

Alzheimer's Disease, Chronic Cluster Headache, Episodic Cluster Headache, Migraine

Studies at this site

• A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache — Completed
• A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine — Completed
• A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease Dementia — Stopped early